Agilent Technologies and Chungnam National University Announce Glycomics Research Initiatives
News Apr 02, 2013
Building on an earlier collaboration, Agilent and the university’s Graduate School of Analytical Science and Technology (GRAST) will establish the Asia Glycomics Education Center to support collaborative university/industry education and cross-training. The university will develop and administer training programs for various methods of glycan analysis, which will be made available without charge to scientists and researchers endorsed by Agilent in South Korea and the South Asia-Pacific region.
“Since we first started collaborating with Agilent in 2011, our university has enjoyed access to the latest analytical and scientific technologies for research in glycomics. Our highly talented team at GRAST, led by professor Hyun-Joo An, has made a number of significant findings, which have been shared with the global scientific community through papers and speaking engagements,” said university president Sang-Chul Jung. “This lives up to our university’s motto—‘Creativity, development, and service to the community’—and we are pleased to further this collaboration with Agilent.”
“In science, discovery is a long and arduous road dependent on the best people, process and technology,” said Rod Minett, general manager of Agilent’s Life Sciences Group in South Korea and the South Asia-Pacific region. “For this collaboration with Chungnam National University, we are going into the next phase of our journey to develop and enhance the biosimilars industry, which will help scientists develop new treatments to cure or prevent diseases.”
Collaborative research between Agilent and leading academic researchers worldwide serves as the company’s means of giving back to communities in which it does business. At the Asia Glycomics Education Center, Agilent will install a state-of-the-art Agilent 6540 Quadrupole Time-of-Flight with Chip/2D nanoHPLC system. The new system will be used to develop novel applications or analytical methods in the field of glycomics and glycoproteomics.
“Around the world, we have seen greater interest among scientists and researchers in the area of glycomic research,” said professor An. “Through our research, we are often pushing the frontiers of science and the capabilities of our analytical instruments. We are thrilled to continue this partnership with Agilent.”
Professor An, who heads the Asia Glycomics Education Center, will continue to work with Dr. Rudolf Grimm, Agilent’s director of science and technology and manager of collaborations in the Asia-Pacific region. “This is an important next-step for both Agilent and Chungnam National University as we continue to build talent and drive innovations and discoveries in the field of glycomics using industry-leading analytical solutions,” said Dr. Grimm.
CMC Biologics Announces Development and Manufacturing Agreement with Harpoon TherapeuticsNews
Companies have entered into agreement for the development and manufacturing of three TriTAC molecules for the treatment of cancers.READ MORE
Serialization Capabilities Now Operational at Lonza Edinburgh Facility for Liquid-Filled Hard CapsulesNews
Investment in former Capsugel site improves anti-counterfeiting security for Lonza’s global supply chain.READ MORE
Changes Identified in Body Cells During Type2 Diabetes OnsetNews
Researchers have found fresh evidence to explain the processes that occur in the body’s cells leading to the onset of type2 diabetes. Utilising metabolomics, results showed that amino acids play a contributory role in the onset of type2 diabetes in some younger and older patients, as the metabolism of specific amino acids is adversely affected.